A Study to Test How Well Healthy Men and Women Tolerate Different Doses of BI 706321
Status:
Completed
Trial end date:
2020-11-25
Target enrollment:
Participant gender:
Summary
The main objectives of this trial are to investigate safety, tolerability and
pharmacokinetics (PK) of BI 706321 in healthy male and female subjects following oral
administration of multiple rising doses for 14 days.